Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Kyowa Hakko Succeeds in Producing Antibodies with High ADCC
January 21, 2002
- Wholesalers Environment to Be Tougher This Year: EAD Director
January 21, 2002
- First Survey on Diabetic Neuropathy Conducted in Japan: JPA
January 21, 2002
- NHI Price System Reform to Give Incentives to New Drugs: PFSB Director General
January 21, 2002
- Korosho Starts Research to Clarify Causes of 3 Severe ADRs
January 21, 2002
- Birth Rate Lowest Ever Recorded, Continuing Trend of Fewer Children
January 21, 2002
- University of Tokyo to Abolish Master Degree System
January 21, 2002
- REGULATORY NEWS IN BRIEF
January 21, 2002
- Criteria for Compensation for AE Sustained in Clinical Trials Needed: JSCPT
January 21, 2002
- Foreign Firm Are Enthusiastic about Increasing Number of MRs: Survey
January 21, 2002
- NEDO Selects Technology Research Projects for Funding in 2001
January 21, 2002
- Use of Celera Genomics Database Expanding in Japan
January 21, 2002
- Pharmacy-based Pharmacists Show Sharp Increase: Medical Professional Survey
January 21, 2002
- Company Leaders Express Commitment to Reform: New Year Addresses
January 21, 2002
- Results of Survey on Clinical Studies Announced
January 21, 2002
- Meiji Seika to Concentrate on Infectious Diseases
January 21, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 21, 2002
- Kirin's Pharma Business Policy for FY2002 Announced
January 21, 2002
- Saitama Drugstore Chain Greencross-coa to Acquire Ikeno
January 21, 2002
- 2002 to Be an Exciting Year: Mr Bessho of Suzuken
January 21, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…